跳至主要内容
临床试验/EUCTR2014-002096-29-AT
EUCTR2014-002096-29-AT进行中(未招募)不适用

Application of Intrawound Vancomycin Powder in Spinal Fusion Surgery to Reduce Postoperative Surgical Site Infections - A Prospective Randomized Controlled Trial

Speising Orthopaedic Hospital Vienna0 个研究点开始时间: 2015年6月18日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Planned TLIF (transforaminal lumbar interbody fusion) or PLIF (posterolateral lumbar interbody fusion) surgery
  • TLIF/PLIF fusion length of one or two motion-segments OR
  • One motion-segment TLIF/PLIF in conjunction with one motion-segment decompression surgery or microscopic disc surgery (microdiscectomy)
  • Fusions within L1 (first lumbar vertebra) through S1 (sacrum)
  • Age of 18-years or older
  • Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 240

排除标准

  • Preoperative inflammatory or infectious state (C-reactive protein levels above 5mg/l)
  • Diabetes mellitus type I or II
  • Allergic to vancomycin, teicoplanin or penicillin
  • Preexisting malignant disease
  • Preexisting auto-immune disease with an impaired immune system
  • Current post-traumatic vertebral injury (e.g. vertebral split fracture)
  • Preexisting Renal impairment
  • Preexisting cochlea damage
  • The surgery cannot be undertaken for any other reasons

研究者

发起方
Speising Orthopaedic Hospital Vienna

相似试验